drugset
drugset / Trial / NCT04767815

To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers

NCT04767815 ↗

Phase 1 Completed 36 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

The pharmacokinetics (PK) and safety of single oral dose of DWN12088 in healthy adults will be compared and assessed on an empty stomach, after high-fat meal, or 2 hours after high-fat meal.

Timeline

Start
2021-03-22
Primary completion
2021-05-31
Completion
2021-06-04

Drugs

EvaluationDrugModalityDoseRoute
Subject BERSIPOROCIN Small molecule 200 mg Oral

Indications

idiopathic pulmonary fibrosis